BioSpace News Archive

Centene Corporation announced that it has priced its previously announced underwritten public offering of $2,200,000,000 aggregate principal amount of 2.50% senior notes due 2031.

Advanced Chemotherapy Technologies, Inc., a clinical-stage drug delivery company, announced today that it has closed a Series A investment of $2.5 million with Spectrum Financial.

Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the closing of the underwriters’ over-allotment option in full, bringing total follow-on public offering proceeds to $10.35 million.

Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, today announced that it has closed the previously announced registered direct offering for the sale of an aggregate of 3,000,000 shares of its common stock for gross proceeds of approximately $23 million,

Cancer Genetics, Inc., a leader in drug discovery and preclinical oncology and immuno-oncology services, announced that it has entered into securities purchase agreements with certain healthcare-focused institutional investors to raise approximately $17.5 million through the issuance of 2,777,778 shares of its common stock at a purchase price of $6.30 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules.

Core One Labs Inc. is pleased with the tremendous turnout on the International Investors’ Call held earlier.

Zymo Research announced their COVID-19 Variant Sequencing Service. This new global service expands Zymo Research’s end-to-end SARS-CoV-2 solutions that include sample collection, RNA extraction, and SARS-CoV-2 detection.

Fact.MR, a global research & consulting firm, in their latest edition of the report, projected that the osteoporosis testing market is likely to foresee a steady growth pace in 2021 & beyond.

The global chondroblastoma treatment market is majorly driven by increasing incidences of this type of bone cancer and therefore the need for treating and managing this cancer.

Oral anticoagulants have been used by clinicians in patients with thrombotic conditions, most notably in stroke prevention in AF.